• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 30, 2023 at 10:52: AM
via Weeks after annoying analysts with a “half-baked” data drop, CureVac is back with more clinical trial results on its GSK-partnered mRNA vaccines against influenza and COVID-19. The update fills a key hole in the earlier release by providing an early look at how the vaccines perform in older adults.

article source
 




Top Bottom
Back
Quote